LD-2 disclosure · 2nd Quarter - Report
ULTRAGENYX PHARMACEUTICAL, INC.
via MEHLMAN CONSULTING, INC.
Client
- Name
- ULTRAGENYX PHARMACEUTICAL, INC.
- Description
- Biopharmaceutical Company
- Location
- California · United States of America
Registrant
- Firm
- MEHLMAN CONSULTING, INC.
- Description
- Government Affairs Consulting Services
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues relating to rare disease and patient access.
LobbyistsDEAN ROSEN · mr DAVID R THOMAS · ELISE FINLEY PICKERING · BRUCE MEHLMAN · SAGE EASTMAN · LAUREN ARONSON · MICHAEL ROBINSON · HELEN TOLAR · NICHOLE DISTEFANO · PAUL THORNELL · ALEXANDER PERKINS · ROSEMARY GUTIERREZ · STEPHEN M. COTE · ZACHARY MALLOVE · CAITLIN VAN SANT · LISA GOLDMAN · ALYENE MLINAR · ms ERICA JAY CHABOT · ANNIE WOLF · NAVEEN PARMAR · JON ADAME · mr JOSEPH EDWARD BROWN iii · EARL SCOTT FLOOD
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
FY27 Appropriations (H.R.8646, Agriculture, Rural Development, Food and Drug Administration)
LobbyistsDEAN ROSEN · mr DAVID R THOMAS · ELISE FINLEY PICKERING · BRUCE MEHLMAN · SAGE EASTMAN · LAUREN ARONSON · MICHAEL ROBINSON · HELEN TOLAR · NICHOLE DISTEFANO · PAUL THORNELL · ALEXANDER PERKINS · ROSEMARY GUTIERREZ · STEPHEN M. COTE · ZACHARY MALLOVE · CAITLIN VAN SANT · LISA GOLDMAN · ALYENE MLINAR · ms ERICA JAY CHABOT · ANNIE WOLF · NAVEEN PARMAR · JON ADAME · mr JOSEPH EDWARD BROWN iii · EARL SCOTT FLOOD
TargetedSENATE · HOUSE OF REPRESENTATIVES